• Health & Medicine

Pelvis-targeting radiotherapy safe for prostate cancer patients

A form of radiotherapy targeting the pelvis is safe for men with advanced localised prostate cancer, according to a new study. A form of radiotherapy targeting the pelvis is safe for men with advanced localised prostate cancer, according to a new study.

26 September 2017

• Health & Medicine

Two treatments for advanced prostate cancer bring equal benefits

Unpublished results from the Cancer Research UK-funded STAMPEDE trial show that two different treatments improve survival in men with advanced prostate cancer. Unpublished results from the Cancer Research UK-funded STAMPEDE trial show that two different treatments improve survival in men with advanced prostate cancer.

8 September 2017

• Health & Medicine

How light and sound give physicists a clearer picture of cancer

Physicists in Cambridge are using light and sound to gather information on prostate cancer in mice. This could show doctors how aggressive a tumour is. Physicists in Cambridge are using light and sound to gather information on prostate cancer in mice. This could show doctors how aggressive a tumour is.

24 August 2017

• Science & Technology

New imaging technique spots prostate tumours starved of oxygen

A new imaging technique uncovers oxygen levels in prostate tumours and could lead to a non-invasive way to determine which tumours are more difficult to treat. A new imaging technique uncovers oxygen levels in prostate tumours and could lead to a non-invasive way to determine which tumours are more difficult to treat.

24 August 2017

• Health & Medicine

‘Nothing to lose and everything to gain’ – Alfred’s story

Read Alfred's story of joining the STAMPEDE clinical trial. His is one of the many stories featured in our 2016/17 Annual Review. Read Alfred's story of joining the STAMPEDE clinical trial. His is one of the many stories featured in our 2016/17 Annual Review.

24 July 2017

• Science & Technology
• Health & Medicine

ASCO 2017: 4 ways treatment could change following world’s largest cancer conference

Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine. Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.

19 June 2017

• Health & Medicine

Blood test could help personalise treatment for advanced prostate cancer

Scientists have developed a blood test that could help doctors select the best treatment for men with aggressive prostate cancer. Scientists have developed a blood test that could help doctors select the best treatment for men with aggressive prostate cancer.

19 June 2017

• Health & Medicine
• Science & Technology

‘Once in a career feeling’ as trial shows offering prostate cancer drug earlier improves survival

We take a look at results from the STAMPEDE clinical trial, which is researching how to improve treatment for men with prostate cancer. We take a look at results from the STAMPEDE clinical trial, which is researching how to improve treatment for men with prostate cancer.

6 June 2017

• Health & Medicine

Giving prostate cancer drug earlier extends lives of men whose disease has spread

Offering abiraterone (Zytiga) up-front with standard hormone treatment extends survival in men whose prostate cancer has spread. Offering abiraterone (Zytiga) up-front with standard hormone treatment extends survival in men whose prostate cancer has spread.

3 June 2017

• Health & Medicine

Adding abiraterone to standard treatment improves prostate cancer survival by 40 per cent

Adding abiraterone to hormone therapy at the start of treatment for prostate cancer improves survival by 37 per cent. Adding abiraterone to hormone therapy at the start of treatment for prostate cancer improves survival by 37 per cent.

3 June 2017

• Science & Technology
• Health & Medicine

Experimental blood test predicts advanced prostate cancer outcome

A blood test could help predict which advanced prostate cancer patients are likely to do best when treated with certain targeted treatments. A blood test could help predict which advanced prostate cancer patients are likely to do best when treated with certain targeted treatments.

4 May 2017

• Health & Medicine

Hormone drug and radiotherapy ‘could extend lives’ of prostate cancer patients after surgery

Men with a high risk of prostate cancer recurrence could live longer if hormone treatment is given alongside radiotherapy after surgery. Men with a high risk of prostate cancer recurrence could live longer if hormone treatment is given alongside radiotherapy after surgery.

3 February 2017